申请人:CONCERT PHARMACEUTICALS INC
公开号:WO2011011712A1
公开(公告)日:2011-01-27
This invention relates to novel substituted imidazotriazines and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound showing partial-agonist activity at the GABA α2, α3 and α5 subtype receptors, and antagonist activity at the αl subtype receptor.
这项发明涉及新型取代咪唑三嗪及其药用盐。该发明还提供了包括本发明化合物的组合物,并将这种组合物用于治疗通过给予显示GABA α2、α3和α5亚型受体部分激动剂活性和α1亚型受体拮抗活性的化合物有益治疗的疾病和症状的方法。